ICU Daily Progress Note

Date: 1 November 2024 Name: John Doe ICU Day 5 Assessment Diagnoses: Acute Respiratory Distress Syndrome (ARDS) secondary to Severe Sepsis, Community-Acquired Pneumonia, Type 2 Diabetes Mellitus. Course over the Last 24 Hours and Subjective: Mr. Doe's wife reported he seemed more alert this morning, occasionally opening his eyes to voice commands. She expressed concern about his prolonged intubation. Pain assessment conducted via CPOT scale due to sedation, scores consistently 2/8. No explicit subjective complaints from the patient given his sedated state. The patient's clinical course over the last 24 hours has shown a slight improvement in oxygenation parameters. He experienced a brief episode of hypotension overnight which responded well to a bolus of normal saline. Weaning parameters for the ventilator have been assessed, and a trial of reduced sedation is planned for later today. Objective: Vital Signs: Temperature: 37.2°C, Heart Rate: 88 bpm, Blood Pressure: 110/65 mmHg (MAP 80), Respiratory Rate: 16 bpm (ventilator set), Oxygen Saturation: 94% on 60% FiO2. Central venous pressure 10 mmHg. Physical Examination: General appearance: Intubated, sedated but responsive to deep stimuli. Appears comfortable. Level of consciousness: RASS -3. Cardiovascular examination: S1S2 present, no murmurs, regular rhythm, good peripheral pulses, capillary refill <2 seconds. Pulmonary examination: Coarse crackles bilaterally in lung bases, diminished breath sounds over the right lower lobe. Trachea midline. Abdominal examination: Soft, non-tender, non-distended, normoactive bowel sounds. Neurological examination: Pupils 3mm and reactive bilaterally. Withdraws from painful stimuli in all four extremities. Extremities and skin examination: Warm and dry, no oedema, intact skin with no new pressure areas. Ventilator Settings and Respiratory Status: Current ventilator mode: PRVC, FiO2: 0.6, PEEP: 10 cmH2O, Tidal Volume: 400ml, Respiratory Rate: 16. Arterial blood gas results (07:00 AM): pH 7.36, PaCO2 48 mmHg, PaO2 78 mmHg, HCO3 26 mmol/L, Lactate 1.8 mmol/L. Respiratory mechanics: Plateau pressure 28 cmH2O, static compliance 35 ml/cmH2O. Haemodynamic Support: Noradrenaline at 0.05 mcg/kg/min (no recent titration). No inotropic support. Haemodynamic monitoring: CVP 10 mmHg, MAP 80 mmHg. Devices and Lines: Right internal jugular central venous catheter, right radial arterial line, endotracheal tube in situ (22 cm at the lip). Nasogastric tube in good position, draining minimal gastric secretions. Foley urinary catheter in situ, draining clear yellow urine. No other devices. Laboratory Results: Full blood count: WBC 14.5 x 10^9/L, Hb 9.8 g/dL, Platelets 220 x 10^9/L. Metabolic panel: Na 138 mmol/L, K 4.1 mmol/L, Cr 1.1 mg/dL, Glucose 145 mg/dL. Coagulation studies: PT 13.5 sec, INR 1.1, PTT 32 sec. Microbiology results: Sputum culture from 3 days ago grew Pseudomonas aeruginosa, sensitive to piperacillin/tazobactam. Blood cultures remain negative. Intake and Output: 24-hour fluid balance: +500 ml (Input 2500ml, Output 2000ml including 1800ml urine and 200ml NG output). Nutritional status: Receiving continuous enteral feeds via NG tube at 40 ml/hour, tolerating well without abdominal distension or high gastric residuals. Assessment: The patient, Mr. John Doe, remains critically ill with ARDS secondary to severe sepsis and pneumonia. His oxygenation has marginally improved over the last 24 hours, and he shows some signs of increased alertness. The mild hypotension was transient and resolved with fluid. Respiratory mechanics indicate moderate ARDS, and the plateau pressures are acceptable. The current antibiotic regimen is appropriate given the identified pathogen. Overall, a cautious optimism for gradual improvement is warranted, but the patient remains high-risk. Response to current therapies: Responding well to current ventilator settings, antibiotics, and vasopressor support. Minimal fluctuation in haemodynamics. Identification of active problems: ARDS, Sepsis (resolving), Pseudomonas pneumonia, Ventilator-associated pneumonia risk, Hyperglycaemia, Sedation management. Plan: Ventilator management plan: Continue PRVC. Attempt a spontaneous breathing trial (SBT) later this morning if RASS improves to -2 or better and other parameters are stable. Aim for extubation if SBT is successful. Haemodynamic support adjustments: Continue current Noradrenaline dose; monitor closely for further blood pressure fluctuations. Medication changes or additions: Continue current antibiotic regimen (Piperacillin/Tazobactam). Titrate sedation to achieve RASS -2 to -1 for SBT. Continue insulin drip for glucose control. Monitoring parameters and frequency: Continue hourly vital signs, I/O, and continuous SpO2/ECG. Daily ABGs. Planned procedures or interventions: Daily chest X-ray to monitor lung fields. Consider bronchoscopy if no further improvement in oxygenation or new infiltrates. Goals for the day: Successful SBT, potential extubation, continued haemodynamic stability, and control of infection.